Crossject Financial Statements From 2010 to 2024
| ALCJ Stock | EUR 2.05 0.07 3.54% |
Check Crossject financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Crossject's main balance sheet or income statement drivers, such as , as well as many indicators such as . Crossject financial statements analysis is a perfect complement when working with Crossject Valuation or Volatility modules.
Crossject |
Crossject Company Current Valuation Analysis
Crossject's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Crossject Current Valuation | 123.81 M |
Most of Crossject's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Crossject is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Crossject has a Current Valuation of 123.81 M. This is 99.14% lower than that of the Health Care Equipment & Supplies sector and 98.65% lower than that of the Health Care industry. The current valuation for all France stocks is 99.26% higher than that of the company.
Crossject Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Crossject's current stock value. Our valuation model uses many indicators to compare Crossject value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Crossject competition to find correlations between indicators driving Crossject's intrinsic value. More Info.Crossject is rated fifth in return on equity category among its peers. It is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Crossject by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Crossject's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Crossject Financial Statements
Crossject stakeholders use historical fundamental indicators, such as Crossject's revenue or net income, to determine how well the company is positioned to perform in the future. Although Crossject investors may analyze each financial statement separately, they are all interrelated. For example, changes in Crossject's assets and liabilities are reflected in the revenues and expenses on Crossject's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Crossject. Please read more on our technical analysis and fundamental analysis pages.
Crossject Socit Anonyme develops needle-free injection systems. The company was founded in 1997 and is based in Dijon, France. CROSSJECT is traded on Paris Stock Exchange in France.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Crossject Stock
Crossject financial ratios help investors to determine whether Crossject Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Crossject with respect to the benefits of owning Crossject security.